797 related articles for article (PubMed ID: 15456464)
41. On the histogenesis of Barrett's oesophagus and its associated squamous islands: a three-dimensional study of their morphological relationship with native oesophageal gland ducts.
Coad RA; Woodman AC; Warner PJ; Barr H; Wright NA; Shepherd NA
J Pathol; 2005 Aug; 206(4):388-94. PubMed ID: 15926200
[TBL] [Abstract][Full Text] [Related]
42. Reflux, Barrett's oesophagus and adenocarcinoma: burning questions.
Wild CP; Hardie LJ
Nat Rev Cancer; 2003 Sep; 3(9):676-84. PubMed ID: 12951586
[TBL] [Abstract][Full Text] [Related]
43. [Barrett esophagus--an increasing problem].
Berstad A; Hatlebakk JG; Giercksky KE
Tidsskr Nor Laegeforen; 1998 Oct; 118(26):4100-3. PubMed ID: 9844516
[TBL] [Abstract][Full Text] [Related]
44. The length of newly diagnosed Barrett's oesophagus and prior use of acid suppressive therapy.
El-Serag HB; Aguirre T; Kuebeler M; Sampliner RE
Aliment Pharmacol Ther; 2004 Jun; 19(12):1255-60. PubMed ID: 15191506
[TBL] [Abstract][Full Text] [Related]
45. Prevalence and risk factors associated with specialized intestinal metaplasia at the esophagogastric junction.
Kamberoglou DK; Savva SC; Kalapothakos PN; Koukounas ND; Doulgeroglou VG; Patra EG; Tzias VD
Hepatogastroenterology; 2002; 49(46):995-8. PubMed ID: 12143262
[TBL] [Abstract][Full Text] [Related]
46. Prevalence of metaplasia at the gastro-oesophageal junction.
Spechler SJ; Zeroogian JM; Antonioli DA; Wang HH; Goyal RK
Lancet; 1994 Dec; 344(8936):1533-6. PubMed ID: 7983953
[TBL] [Abstract][Full Text] [Related]
47. Surgical options and outcomes in Barrett's esophagus.
Zaninotto G; Rizzetto C
Curr Opin Gastroenterol; 2007 Jul; 23(4):452-5. PubMed ID: 17545785
[TBL] [Abstract][Full Text] [Related]
48. [Intestinal metaplasia at the gastroesophageal junction - epidemiologic and histologic aspects. Report of 164 cases].
Chaabouni H; Haouet S; Cheikh I; Amouri A; Kchaou M; Zargouni H; Ben Mami N; Zitouna MM; Ben Ammar A
Tunis Med; 2001; 79(6-7):353-60. PubMed ID: 11771430
[TBL] [Abstract][Full Text] [Related]
49. Acid reflux and oesophageal cancer.
Nicholson A; Jankowski J
Recent Results Cancer Res; 2011; 185():65-82. PubMed ID: 21822820
[TBL] [Abstract][Full Text] [Related]
50. Microsatellite analysis provides evidence of neoplastic transformation in long-segment, but not in short-segment, Barrett's oesophagus.
Gleeson CM; McDougall NI; Russell SE; McGuigan JA; Collins JS; Sloan JM
Int J Cancer; 2000 Feb; 85(4):482-5. PubMed ID: 10699918
[TBL] [Abstract][Full Text] [Related]
51. Risk of oesophageal cancer in Barrett's oesophagus and gastro-oesophageal reflux.
Solaymani-Dodaran M; Logan RF; West J; Card T; Coupland C
Gut; 2004 Aug; 53(8):1070-4. PubMed ID: 15247170
[TBL] [Abstract][Full Text] [Related]
52. Barrett's oesophagus: from metaplasia to dysplasia and cancer.
Fléjou JF
Gut; 2005 Mar; 54 Suppl 1(Suppl 1):i6-12. PubMed ID: 15711008
[TBL] [Abstract][Full Text] [Related]
53. [Quantification of gastro-esophageal reflux in Barrett's esophagus].
Ortiz Escandell A; Martínez de Haro LF; Parrilla Paricio P; Molina Martínez J; Aguayo Albasini JL; Martínez Gómez D
Rev Esp Enferm Dig; 1990 Mar; 77(3):171-5. PubMed ID: 2378753
[TBL] [Abstract][Full Text] [Related]
54. When and how to grade Barrett's columnar metaplasia: the Prague system.
Anand O; Wani S; Sharma P
Best Pract Res Clin Gastroenterol; 2008; 22(4):661-9. PubMed ID: 18656823
[TBL] [Abstract][Full Text] [Related]
55. [Endoscopic diagnosis of Barrett's esophagus].
Hoshihara Y; Kogure T; Yamamoto T; Hashimoto M; Hoteya O
Nihon Rinsho; 2005 Aug; 63(8):1394-8. PubMed ID: 16101228
[TBL] [Abstract][Full Text] [Related]
56. Daily use of non-steroidal anti-inflammatory drugs is less frequent in patients with Barrett's oesophagus who develop an oesophageal adenocarcinoma.
Tsibouris P; Hendrickse MT; Isaacs PE
Aliment Pharmacol Ther; 2004 Sep; 20(6):645-55. PubMed ID: 15352913
[TBL] [Abstract][Full Text] [Related]
57. [Revision needed of follow-up policy for Barrett's esophagus].
Giard RW; Coebergh JW; Ouwendijk RJ
Ned Tijdschr Geneeskd; 2002 Jan; 146(4):150-4. PubMed ID: 11845562
[TBL] [Abstract][Full Text] [Related]
58. Barrett's esophagus.
Bonino JA; Sharma P
Curr Opin Gastroenterol; 2005 Jul; 21(4):461-5. PubMed ID: 15930989
[TBL] [Abstract][Full Text] [Related]
59. Does Barrett's oesophagus develop over time in patients with chronic gastro-oesophageal reflux disease?
Stoltey J; Reeba H; Ullah N; Sabhaie P; Gerson L
Aliment Pharmacol Ther; 2007 Jan; 25(1):83-91. PubMed ID: 17229223
[TBL] [Abstract][Full Text] [Related]
60. Activation of Akt is increased in the dysplasia-carcinoma sequence in Barrett's oesophagus and contributes to increased proliferation and inhibition of apoptosis: a histopathological and functional study.
Beales IL; Ogunwobi O; Cameron E; El-Amin K; Mutungi G; Wilkinson M
BMC Cancer; 2007 Jun; 7():97. PubMed ID: 17559672
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
